Compare JSPR & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JSPR | MASS |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.4M | 324.4M |
| IPO Year | N/A | 2020 |
| Metric | JSPR | MASS |
|---|---|---|
| Price | $1.81 | $5.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 2 |
| Target Price | ★ $25.60 | $9.00 |
| AVG Volume (30 Days) | ★ 3.8M | 361.8K |
| Earning Date | 11-10-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $65,045,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 36.21 |
| 52 Week Low | $1.39 | $1.81 |
| 52 Week High | $23.11 | $9.34 |
| Indicator | JSPR | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 46.29 | 39.13 |
| Support Level | $1.60 | $6.26 |
| Resistance Level | $1.93 | $6.83 |
| Average True Range (ATR) | 0.20 | 0.39 |
| MACD | 0.03 | 0.07 |
| Stochastic Oscillator | 36.90 | 7.94 |
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.